Online citations, reference lists, and bibliographies.
Please confirm you are human
(Sign Up for free to never see this)
← Back to Search

Synthesis Of Poly(alkyl Cyanoacrylate)-based Colloidal Nanomedicines.

J. Nicolas, P. Couvreur
Published 2009 · Materials Science, Medicine

Save to my Library
Download PDF
Analyze on Scholarcy
Share
Nanoparticles developed from poly(alkyl cyanoacrylate) (PACA) biodegradable polymers have opened new and exciting perspectives in the field of drug delivery due to their nearly ideal characteristics as drug carriers in connection with biomedical applications. Thanks to the direct implication of organic chemistry, polymer science and physicochemistry, multiple PACA nanoparticles with different features can be obtained: nanospheres and nanocapsules (either oil- or water-containing) as well as long-circulating and ligand-decorated nanoparticles. This review aims at emphasizing the synthetic standpoint of all these nanoparticles by describing the important aspects of alkyl cyanoacrylate chemistry as well as the experimental procedures and the different techniques involved for the preparation of the corresponding colloidal devices.
This paper references
10.1016/S0168-3659(99)00063-2
Stealth PEGylated polycyanoacrylate nanoparticles for intravenous administration and splenic targeting.
M. Peracchia (1999)
10.1002/CHIN.200422068
Phosphane-Catalyzed Knoevenagel Condensation: A Facile Synthesis of α-Cyanoacrylates and α-Cyanoacrylonitriles.
J. S. Yadav (2004)
10.1021/jo00132a019
Cycloaddition and polymerization reactions of methyl .alpha.-cyanoacrylate with electron-rich olefins
H. A. A. Rasoul (1982)
10.1016/S0024-3205(97)00539-0
Complement consumption by poly(ethylene glycol) in different conformations chemically coupled to poly(isobutyl 2-cyanoacrylate) nanoparticles.
M. Peracchia (1997)
Alkylcyanoacrylatedrug carriers. 2. cytotoxicity of cyanboacrylate nanoparticles with different alkyl chain-length
C Lherm (1992)
10.1016/0142-9612(90)90084-4
In vitro model for the degradation of alkylcyanoacrylate nanoparticles.
R. H. Müller (1990)
10.1097/00000637-200102000-00020
Expanded Applications for Octyl-2-cyanoacrylate as a Tissue Adhesive
G. Hallock (2001)
10.1016/S0090-4295(00)01075-X
Comparison of 2-octyl cyanoacrylate adhesive, fibrin glue, and suturing for wound closure in the porcine urinary tract.
R. Marcovich (2001)
10.1295/POLYMJ.9.307
Solvent Effect on Radical Polymerization of Phenyl Methacrylate
M. Kamachi (1977)
10.1021/MA00128A062
Block copolymer nanoparticles of ethylene oxide and isobutyl cyanoacrylate
Y. K. Choi (1995)
10.1080/19996205-199924100-00005
Tissue adhesives: a new method of wound repair.
M. E. King (1999)
10.1023/A:1007582332491
Polyisobutylcyanoacrylate Nanocapsules Containing an Aqueous Core as a Novel Colloidal Carrier for the Delivery of Oligonucleotides
G. Lambert (2004)
10.1007/s00018-005-5094-3
A relevant in vitro rat model for the evaluation of blood-brain barrier translocation of nanoparticles
É. Garcia-Garcia (2005)
10.1002/POLA.1989.080270617
Hydrolysis of alkyl cyanoacrylate and ethoxycarbonylpropenoylphosphonate polymers
A. J. Cooper (1989)
10.1002/MACP.1981.021820212
Polymerisation via macrozwitterions, 2. Ethyl and butyl cyanoacrylates polymerised by pyridine and polyvinylpyridine†
D. S. Johnston (1981)
10.1016/S0002-9610(01)00742-5
A prospectus on tissue adhesives.
T. Reece (2001)
Transesterification method and catalysts for making cyanoacrylates from cyanoacetates . US Patent No . 2001036380
B Malofsky (2003)
10.1016/S0142-9612(00)00286-6
Poly n-butyl cyanoacrylate nanoparticles: a mechanistic study of polymerisation and particle formation.
N. Behan (2001)
10.1016/J.IJPHARM.2007.01.034
Enhancing the tolerance of poly(isobutylcyanoacrylate) nanoparticles with a modular surface design.
C. Chauvierre (2007)
10.1002/MACP.1989.021901206
Anionic polymerization of butyl cyanoacrylate by tetrabutylammonium salts, 1. Initiation processes
I. C. Eromosele (1989)
10.1021/MA061865L
A Route to Nonfunctionalized and Functionalized Poly(n-butylcyanoacrylate) Nanoparticles: Preparation in Miniemulsion
C. Weiss (2007)
10.1021/MA0007132
Anionic Polymerization of Phenyl Glycidyl Ether in Miniemulsion
C. Maitre (2000)
10.1021/LA060570Y
Properties of polysaccharides grafted on nanoparticles investigated by EPR.
I. Bertholon (2006)
10.1016/0021-9797(84)90015-8
Particle size and size distribution of poly(butyl-2-cyanoacrylate) nanoparticles: I. Influence of physicochemical factors
S. J. Douglas (1984)
10.1124/jpet.102.039669
Poly(ethylene glycol)-Coated Hexadecylcyanoacrylate Nanospheres Display a Combined Effect for Brain Tumor Targeting
I. Brigger (2002)
10.1080/10611860701603372
Design aspects of poly(alkylcyanoacrylate) nanoparticles for drug delivery
C. Vauthier (2007)
10.1023/A:1010931127745
Long-Circulating PEGylated Polycyanoacrylate Nanoparticles as New Drug Carrier for Brain Delivery
P. Calvo (2004)
10.1007/s11095-006-0284-8
Nanotechnology: Intelligent Design to Treat Complex Disease
P. Couvreur (2006)
10.1177/039139880502801114
Nanocapsules as Drug Delivery Systems
C. Mayer (2005)
Monomeric αcyanoacrylates
FB Joyner (1956)
10.1016/J.IJPHARM.2006.10.031
Encapsulation of mono- and oligo-nucleotides into aqueous-core nanocapsules in presence of various water-soluble polymers.
H. Hillaireau (2007)
10.1295/polymj.13.41
Solvent Effect on Radical Polymerization of Methyl Methacrylate
M. Kamachi (1981)
10.1016/0014-3057(76)90064-1
Polymerization of methyl α-cyanoacrylate—II: Conditions for radical polymerization
J. Bevington (1976)
10.1016/J.BIOMATERIALS.2003.09.097
Heparin coated poly(alkylcyanoacrylate) nanoparticles coupled to hemoglobin: a new oxygen carrier.
C. Chauvierre (2004)
Molecularweights of polycyanoacrylate nanoparticles
MA El-Egakey (1983)
10.1021/MA0202890
Cationic Polymerization of p-Methoxystyrene in Miniemulsion
Séverine Cauvin (2002)
10.1002/1521-3927(20000801)21:13<884::AID-MARC884>3.0.CO;2-5
The mechanism of polymerisation of butyl cyanoacrylate in aqueous dispersions
Niall D. Behan (2000)
10.1002/JBM.820290608
Monosize poly(ethylcyanoacrylate) microspheres: preparation and degradation properties.
A. Tuncel (1995)
Particle-size and size distribution of poly(butyl-2-cyanoacrylate) nanoparticles
SJ Douglas (1984)
10.1111/j.2042-7158.1979.tb13510.x
Polycyanoacrylate nanocapsules as potential lysosomotropic carriers: preparation, morphological and sorptive properties
P. Couvreur (1979)
10.1016/J.BIOMATERIALS.2005.01.019
Interactions of blood proteins with poly(isobutylcyanoacrylate) nanoparticles decorated with a polysaccharidic brush.
D. Labarre (2005)
10.1021/MA0257402
Anionic Polymerization of n-Butyl Cyanoacrylate in Emulsion and Miniemulsion
Cédric Limouzin (2003)
10.1016/0378-5173(95)00142-6
Influence of the preparation conditions on poly(ethylcyanoacrylate) nanocapsule formation
G. Puglisi (1995)
10.1002/MACP.1981.021820211
Polymerisation via macrozwitterions, 1. Ethyl and butyl cyanoacrylates polymerised by triethyl and triphenylphosphines
D. S. Johnston (1981)
10.1016/J.JCONREL.2005.04.013
Using different structure types of microemulsions for the preparation of poly(alkylcyanoacrylate) nanoparticles by interfacial polymerization.
K. Krauel (2005)
10.1023/A:1016366022712
Molecular Weights of Free and Drug-Loaded Nanoparticles
Luc Vansnick (2004)
10.1016/0378-5173(94)90371-9
Characterisation of polybutylcyanoarylate nanoparticles: I. Quantification of PCBA polymer and dextrans
K. Langer (1994)
10.1002/POL.1978.170161007
Unequivocal synthesis of bis(2‐cyanoacrylate) monomers. I. Via anthracene adducts
Carl J. Buck (1978)
10.1016/0021-9797(92)90079-2
Optimization of polyalkylcyanoacrylate nanoparticle preparation: Influence of sulfur dioxide and pH on nanoparticle characteristics
F. Lescure (1992)
Transesterification method and catalysts for making cyanoacrylates from cyanoacetates
B Malofsky (2001)
10.1016/J.EJPS.2006.10.007
Tuning of shell and core characteristics of chitosan-decorated acrylic nanoparticles.
I. Bravo-Osuna (2007)
10.1002/EJOC.200300513
Phosphane‐Catalyzed Knoevenagel Condensation: A Facile Synthesis of α‐Cyanoacrylates and α‐Cyanoacrylonitriles
J. S. Yadav (2004)
10.1002/MARC.1996.030170404
Novel sub‐ceiling temperature rapid depolymerization‐repolymerization reactions of cyanoacrylate polymers
B. Ryan (1996)
10.1002/CHIN.198028125
ZWITTERION CYCLOADDITIONS AND FREE-RADICAL POLYMERIZATIONS OF P-(DIMETHYLAMINO)STYRENE WITH TRIS- AND TETRAKIS(CARBOMETHOXY)ETHYLENES
H. K. Hall (1980)
10.1002/ELPS.200600694
Analysis of plasma protein adsorption onto PEGylated nanoparticles by complementary methods: 2‐DE, CE and Protein Lab‐on‐chip® system
H. R. Kim (2007)
10.1016/S0169-409X(03)00041-3
Poly(alkylcyanoacrylates) as biodegradable materials for biomedical applications.
C. Vauthier (2003)
Monomeric alkyl α-cyanoacrylates
AE Ardis (1949)
10.1021/MA60043A006
Electron-Deficient Trisubstituted Olefins. A New Class of Reactive Comonomers
H. Hall (1975)
10.1016/S1051-0443(07)61568-1
The use of cyanoacrylate adhesives in peripheral embolization.
J. Pollak (2001)
10.1016/0378-5173(94)90086-8
Influence of enzymes on the stability of polybutylcyanoacrylate nanoparticles
D. Scherer (1994)
10.1016/J.PROGSOLIDSTCHEM.2005.11.009
Nanotechnologies for drug delivery: Application to cancer and autoimmune diseases
P. Couvreur (2006)
10.1016/J.POLYMER.2004.11.067
Influence of the initiator system, cerium–polysaccharide, on the surface properties of poly(isobutylcyanoacrylate) nanoparticles
I. Bertholon-Rajot (2005)
Polymerization via macrozwitterions
DS Johnston (1981)
10.1002/MACP.1981.021820213
Polymerisation via macrozwitterions, 3. Ethyl and butyl cyanoacrylates polymerised by benzyldimethyl, triethyl and tribenzylamines
D. S. Johnston (1981)
10.1002/1520-6017(200011)89:11<1452::AID-JPS8>3.0.CO;2-P
Design of folic acid-conjugated nanoparticles for drug targeting.
B. Stella (2000)
10.1016/0142-9612(90)90055-U
Modification of synthesis and investigation of properties for 2-cyanoacrylates.
Y. C. Tseng (1990)
10.1002/APP.1960.070041116
Methyl α‐cyanoacrylate. I. Free‐radical homopolymerization
A. Canale (1960)
Emulsion polymerization : a mechanistic approach
R. Gilbert (1995)
10.1002/APP.1965.070090204
Methyl α‐cyanoacrylate. II. Copolymerization studies
J. Kinsinger (1965)
10.1016/0021-9797(85)90087-6
Particle size and size distribution of poly(butyl 2-cyanoacrylate) nanoparticles. II. Influence of stabilizers
S. J. Douglas (1985)
Emulsion polymerization and emulsion polymers
P. A. Lovell (1997)
10.3109/02652049009040475
Joint effects of monomer and stabilizer concentrations on physico-chemical characteristics of poly(butyl 2-cyanoacrylate) nanoparticles.
M. J. Alonso (1990)
10.1002/PI.4980170404
Molecular weights of poly(butyl 2‐cyanoacrylate) produced during nanoparticle formation
S. J. Douglas (1985)
10.1021/MA961453K
Synthesis of a Novel Poly(MePEG cyanoacrylate-co-alkyl cyanoacrylate) Amphiphilic Copolymer for Nanoparticle Technology‡
M. Peracchia (1997)
10.1016/S0142-9612(99)00278-1
Non-adhesive cyanoacrylate as an embolic material for endovascular neurosurgery.
H. Oowaki (2000)
10.1016/0142-9612(84)90002-4
Degradation of poly (isobutyl cyanoacrylate) nanoparticles.
V. Lenaerts (1984)
10.1002/JBM.820140202
In vitro heterogeneous degradation of poly(n‐alkyl α‐cyanoacrylates)
W. R. Vezin (1980)
10.1016/J.IJPHARM.2005.03.031
Colloidal carriers and blood-brain barrier (BBB) translocation: a way to deliver drugs to the brain?
E. García-García (2005)
10.1023/B:PHAM.0000003376.57954.2a
Novel Polysaccharide-Decorated Poly(Isobutyl Cyanoacrylate) Nanoparticles
C. Chauvierre (2004)
10.1007/s00018-007-6390-x
Low-density lipoprotein receptor-mediated endocytosis of PEGylated nanoparticles in rat brain endothelial cells
H. R. Kim (2007)
A process for preparation of high purity octyl and isoamylcyanoacrylates
CC Sahadev (2003)
10.1002/CPHC.200400527
Nanoparticles and nanocapsules created using the Ouzo effect: spontaneous emulisification as an alternative to ultrasonic and high-shear devices.
Ganachaud François (2005)
10.1016/0378-5173(86)90021-9
Biodistribution of poly(butyl 2-cyanoacrylate) nanoparticles in rabbits
S. J. Douglas (1986)
10.1016/S0378-5173(96)04830-2
Preparation of pseudolatex by nanoprecipitation: Influence of the solvent nature on intrinsic viscosity and interaction constant
O. Thioune (1997)
10.1021/MA034097W
Radical Emulsion Polymerization of Alkylcyanoacrylates Initiated by the Redox System Dextran-Cerium(IV) under Acidic Aqueous Conditions
C. Chauvierre (2003)
10.1016/0192-0561(94)90036-1
Anti-metastatic activity of MDP-L-alanyl-cholesterol incorporated into various types of nanocapsules.
G. Barratt (1994)
10.1002/(SICI)1097-4636(19970305)34:3<317::AID-JBM6>3.0.CO;2-N
Development of sterically stabilized poly(isobutyl 2-cyanoacrylate) nanoparticles by chemical coupling of poly(ethylene glycol).
M. Peracchia (1997)
10.1002/MACP.1983.021840214
Initiation processes in polymerizations of alkyl cyanoacrylates by tertiary amines: Inhibition by strong acids
D. C. Pepper (1983)
10.1021/BM060711A
Translocation of poly(ethylene glycol-co-hexadecyl)cyanoacrylate nanoparticles into rat brain endothelial cells: role of apolipoproteins in receptor-mediated endocytosis.
H. R. Kim (2007)
10.1016/0169-409X(95)00039-A
Surface modification of nanoparticles to oppose uptake by the mononuclear phagocyte system
G. Storm (1995)
10.1023/A:1023267304096
The Stenlying Effect of High Hydrostatic Pressure on Thermally and Hydrolytically Labile Nanosized Carriers
I. Brigger (2004)
10.1016/S0142-9612(99)00021-6
Visualization of in vitro protein-rejecting properties of PEGylated stealth polycyanoacrylate nanoparticles.
M. Peracchia (1999)
Methyl a-cyanoacrylate. I
AJ Canale (1960)
10.1021/ja00837a020
Reactions of the zwitterions from trisubstituted electron-deficient ethylenes and electron-rich olefins
H. Hall (1975)
10.1016/S0021-9797(03)00019-5
Pulsed field gradient NMR on polybutylcyanoacrylate nanocapsules.
M. Wohlgemuth (2003)
10.1021/jo01293a015
Zwitterion cycloadditions and free-radical polymerizations of p-(dimethylamino)styrene with tris- and tetrakis(carbomethoxy)ethylenes
H. Hall (1980)
10.1007/S003960050516
Formation of positively charged poly(butyl cyanoacrylate) nanoparticles stabilized with chitosan
S. Yang (2000)
Etude du mécanisme de dégradation des nanoparticules de polycyanoacrylate d’alkyle
D Ley (1984)
Investigation of the formation of sterically stabilized poly(ethylene glycol/isobutyl cyanoacrylate) nanoparticles by chemical grafting of polyethylene glycol during the polymerization of isobutyl cyanoacrylate
M. Peracchia (1997)
10.1046/j.1460-9568.2002.01967.x
Quantification and localization of PEGylated polycyanoacrylate nanoparticles in brain and spinal cord during experimental allergic encephalomyelitis in the rat
P. Calvo (2002)
PEGylated polycyanoacrylate nanoparticles as tumor necrosis factor-alpha carriers.
Y. Li (2001)
10.1002/MACP.1967.021100130
Determination of Q, e parameters for methyl α‐cyanoacrylate
T. Otsu (1967)
10.1002/MACP.1989.021900713
Water effects on the zwitterionic polymerization of cyanoacrylates
I. C. Eromosele (1989)
10.1023/A:1011973625803
Pegylated Nanoparticles from a Novel Methoxypolyethylene Glycol Cyanoacrylate-Hexadecyl Cyanoacrylate Amphiphilic Copolymer
M. Peracchia (2004)
Particle - size and size distribution of poly ( butyl 2 - cyanoacrylate ) nanoparticles . 2 . Influence of stabilizers
SJ Douglas (1985)
A new nanocapsule formulation with hydrophilic core : Application to the oral administration of salmon calcitonin in rats
H. Vranckx (1996)
10.1002/MACP.1983.021840514
Determination of absolute rate constants for radical polymerization and copolymerization of ethyl α‐cyanoacrylate in the presence of effective inhibitors against anionic polymerization
B. Yamada (1983)
Polymerization via macrozwitterions . 2 . Ethyl and butyl cyanoacrylates polymerized by pyridine and poly ( vinylpyridine )
DS Johnston (1977)
10.1295/POLYMJ.12.629
Kinetics and Mechanisms of Zwitterionic Polymerizations of Alkyl Cyanoacrylates
D. C. Pepper (1980)
10.1007/s11095-006-0069-0
Complement Activation by Core–Shell Poly(isobutylcyanoacrylate)–Polysaccharide Nanoparticles: Influences of Surface Morphology, Length, and Type of Polysaccharide
I. Bertholon (2006)
10.1248/BPB.24.662
Stealth polycyanoacrylate nanoparticles as tumor necrosis factor-alpha carriers: pharmacokinetics and anti-tumor effects.
Y. Li (2001)
10.1016/0378-5173(86)90236-X
Development of a new process for the manufacture of polyisobutylcyanoacrylate nanocapsules
N. A. K. Fallouh (1986)
10.1002/MARC.1986.030071004
Free and paired-ion propagation in the polymerization of butyl cyanoacrylate by tetrabutylammonium salts
I. C. Eromosele (1986)
10.1016/0378-5173(92)90210-S
Alkylcyanoacrylate drug carriers: II. Cytotoxicity of cyanoacrylate nanoparticles with different alkyl chain length
C. Lherm (1992)
10.1002/MACP.1988.021890109
Zwitterionic polymerization of butyl cyanoacrylate by triphenylphosphine and pyridine
J. Cronin (1988)
Monomeric α-cyanoacrylates
CG Jeremias (1956)
Polymerization via macrozwitterions . 3 . Ethyl and butyl cyanoacrylates polymerized by benzyldimethyl , triethyl , and tribenzy - lamines
DS Johnston (1981)
10.1016/0378-5173(83)90084-4
Molecular weights of polycyanoacrylate nanoparticles
M. A. Elegakey (1983)
10.1002/(SICI)1097-4636(19991215)47:4<568::AID-JBM14>3.0.CO;2-X
Study of the mechanism of insulin encapsulation in poly(isobutylcyanoacrylate) nanocapsules obtained by interfacial polymerization.
M. Aboubakar (1999)
Recent advances in poly(alkylcyanoacrylate) nanoparticles for drug delivery. Nanoparticles for Pharmaceutical
E Fattal (2008)
10.1002/POL.1977.130150703
Ionic and zwitterionic polymerization of n-alkyl 2-cyanoacrylates
E. Donnelly (1977)
10.1002/MACP.1989.021901207
Anionic polymerization of butyl cyanoacrylate by tetrabutylammonium salts, 2. Propagation rate constants
I. C. Eromosele (1989)
10.1016/0378-5173(93)90075-Q
Study of the mechanisms of formation of nanoparticles and nanocapsules of polyisobutyl-2-cyanoacrylate
M. Gallardo (1993)
10.1016/0378-5173(90)90024-X
Design of nanoparticles of less than 50 nm diameter: preparation, characterization and drug loading
B. Seijo (1990)
10.1002/APP.1966.070100208
Synthesis and degradation of poly (alkyl α-cyanoacrylates)
F. Leonard (1966)
10.1080/02652040600776424
Alkylcyanoacrylate nanocapsules prepared from mini-emulsions: A comparison with the conventional approach
N. Altinbas (2006)
10.1080/10611860290031877
Apolipoprotein-mediated Transport of Nanoparticle-bound Drugs Across the Blood-Brain Barrier
J. Kreuter (2002)
10.1016/0169-409X(95)00025-3
Long circulating microparticulate drug carriers
S. Stolnik (1995)
10.1021/MA060338Z
Characterization of Dextran−Poly(isobutylcyanoacrylate) Copolymers Obtained by Redox Radical and Anionic Emulsion Polymerization
I. Bertholon (2006)



This paper is referenced by
10.1007/s11095-011-0568-5
Click Chemistry for Drug Delivery Nanosystems
E. Lallana (2011)
10.1016/j.ejpb.2015.03.033
Design attributes of long-circulating polymeric drug delivery vehicles.
M. Beck-Broichsitter (2015)
Degradation and Stability of PBCA and POCA Nanoparticles
A. Bøe (2013)
10.1016/j.jcis.2012.08.068
Characterization of the Solutol® HS15/water phase diagram and the impact of the Δ9-tetrahydrocannabinol solubilization.
S. Murgia (2013)
10.1201/B17191-19
Interactions of Polysaccharide-Coated Nanoparticles with Proteins
C. Vauthier (2014)
10.1186/s12645-015-0011-4
Erratum to: Contact-mediated intracellular delivery of hydrophobic drugs from polymeric nanoparticles
Sofie Snipstad (2015)
10.1007/978-3-319-92067-2_20-1
Drug Delivery: Polymers in the Development of Controlled Release Systems
S. Campbell (2019)
10.1081/E-ENN3-120051984
Surface-Modified Nanoparticles to Improve Drug Delivery
Felipe A Oyarzun-Ampuero (2014)
10.1557/OPL.2015.60
Poly( n -butylcyanoacrylate) Nanoparticles as Carriers for Adenosine triphosphate
Christian Wischke (2015)
10.1039/C4PY01423E
Pulsed-laser and quantum mechanics study of n-butyl cyanoacrylate and methyl methacrylate free-radical copolymerization
Thomas R. Rooney (2015)
Biologische Verträglichkeit künstlicher Sauerstoffträger auf Perfluorcarbon-Basis
Julia Laudien (2014)
10.1016/j.jconrel.2013.02.013
Polyalkylcyanoacrylates as in situ formed diffusion barriers in multimaterial drug carriers.
C. Wischke (2013)
10.1002/cmmi.1639
Nanoparticle-stabilized microbubbles for multimodal imaging and drug delivery.
Ý. Mørch (2015)
10.1007/S00396-010-2219-5
Preparation and physicochemical characterization of novel chlorambucil-loaded nanoparticles of poly(butylcyanoacrylate)
G. Yordanov (2010)
10.1021/nn3004372
Versatile and efficient targeting using a single nanoparticulate platform: application to cancer and Alzheimer's disease.
B. Le Droumaguet (2012)
10.1007/BF03449144
Reinforcement of Latex Rubber by the Incorporation of Amphiphilic Particles
S. Kim (2017)
Functionalised dextran nanoparticles for drug delivery to the brain
Daniel Madu Ibegbu (2015)
10.1016/j.ijpharm.2011.01.015
Selegiline-functionalized, PEGylated poly(alkyl cyanoacrylate) nanoparticles: Investigation of interaction with amyloid-β peptide and surface reorganization.
Benjamin Le Droumaguet (2011)
10.3109/02652048.2013.843600
Artificial oxygen carriers based on perfluorodecalin-filled poly(n-butyl-cyanoacrylate) nanocapsules
C. Stephan (2014)
10.1002/POLA.28261
Preparation and functionalization of linear and reductively degradable highly branched cyanoacrylate-based polymers
Houliang Tang (2016)
In vitro characterization of cyanoacrylate embolic glues used for vascular embolization
Y. Li (2017)
10.1016/j.biomaterials.2010.10.026
Protein adsorption and complement activation for di-block copolymer nanoparticles.
C. Vauthier (2011)
10.1039/C3PY01384G
Recent trends in the design of anticancer polymer prodrug nanocarriers
Vianney Delplace (2014)
10.1002/PAT.3305
Biodegradable polymers—an overview†
Sindhu Doppalapudi (2014)
10.1016/j.jmbbm.2017.01.003
Polymerization kinetics of n-butyl cyanoacrylate glues used for vascular embolization.
Y. Li (2017)
10.1080/1061186X.2019.1588280
A journey through the emergence of nanomedicines with poly(alkylcyanoacrylate) based nanoparticles
C. Vauthier (2019)
10.1002/ADEM.201080088
Polymers in Drug Delivery—State of the Art and Future Trends
Stefan Grund (2011)
10.1201/B16966-12
RECENT ADVANCES IN NANOMEDICINE: APPLICATIONS IN DIAGNOSIS AND THERAPEUTICS
S. Gopalakrishnan (2014)
10.1016/j.jcis.2018.10.004
Generation of ultra-stable Pickering microbubbles via poly alkylcyanoacrylates.
Papoole Valadbaigi (2019)
10.2174/138920012798356899
The ligand nanoparticle conjugation approach for targeted cancer therapy.
Nour Karra (2012)
10.1038/S41570-017-0063
Evolution of macromolecular complexity in drug delivery systems.
Ashok Kakkar (2017)
10.1002/MASY.201100058
Highly Flexible Poly(ethyl‐2‐cyanoacrylate) Based Materials Obtained by Incorporation of Oligo(ethylene glycol)diglycidylether
G. Tripodo (2011)
See more
Semantic Scholar Logo Some data provided by SemanticScholar